MetaADEDB 2.0 @ LMMD
Pantoprazole
(IQPSEEYGBUAQFF-UHFFFAOYSA-N)
Structure
SMILES
COc1c(OC)ccnc1CS(=O)c1nc2c([nH]1)cc(cc2)OC(F)F
Type(s)
Approved
ATC code(s)
A02BC02; A02BD04; A02BD11
Molecular Formula:
C16H15F2N3O4S
Molecular Weight:
383.370
Log P:
3.7500
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
1
TPSA:
105.54
CAS Number(s):
102625-70-7; 142706-18-1
Synonym(s)
1.
Pantoprazole
2.
BY 1023
3.
BY-1023
4.
Pantoprazole Sodium
5.
Protonix
6.
SK&F 96022
7.
SK&F-96022
8.
SKF-96022
9.
BY1023
10.
SK&F96022
11.
SKF 96022
12.
SKF96022
External Link(s)
MeSHD000077402
PubChem Compound4679
BindingDB50241342
ChEBI7915
CHEMBLCHEMBL1502
DrugBankDB00213
DrugCentral2054
IUPHAR/BPS Guide to PHARMACOLOGY7260
KEGGcpd:C11806
dr:D05353
Therapeutic Target DatabaseD0T6XX
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 467
Canada Vigilance: 137
Canada Vigilance
US FAERS
2NauseaFAERS: 167
Canada Vigilance: 27
11012560CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
3MalaiseFAERS: 142
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
4DizzinessFAERS: 111
Canada Vigilance: 10
Canada Vigilance
OFFSIDES
SIDER
US FAERS
5HeadacheFAERS: 107
Canada Vigilance: 7
11012560CTD
SIDER
Canada Vigilance
US FAERS
6Drug screen false positiveFAERS: 96US FAERS
7DyspepsiaFAERS: 93
Canada Vigilance: 37
Canada Vigilance
SIDER
US FAERS
8VomitingFAERS: 93
Canada Vigilance: 12
11012560CTD
SIDER
Canada Vigilance
US FAERS
9Product substitution issueFAERS: 89
Canada Vigilance: 92
Canada Vigilance
US FAERS
10PruritusFAERS: 89
Canada Vigilance: 12
Canada Vigilance
SIDER
US FAERS
11PainFAERS: 81
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
12Drug screen positiveFAERS: 79US FAERS
13HypersensitivityFAERS: 79
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
14UrticariaFAERS: 66
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
15Acute kidney injuryFAERS: 6415372423
17014549
CTD
US FAERS
16FatigueFAERS: 61
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
17Chest PainFAERS: 59
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
18Abdominal discomfortFAERS: 56
Canada Vigilance: 18
Canada Vigilance
OFFSIDES
SIDER
US FAERS
19Abdominal PainFAERS: 55
Canada Vigilance: 18
11012560
17475611
CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
20ArthralgiaFAERS: 54
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
21Weight decreasedFAERS: 51
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
22AstheniaFAERS: 48OFFSIDES
SIDER
US FAERS
23ErythemaFAERS: 47
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
24Feeling abnormalFAERS: 47
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
25Back PainFAERS: 46SIDER
US FAERS
26FlatulenceFAERS: 45
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
27AnxietyFAERS: 44SIDER
US FAERS
28MyalgiaFAERS: 43
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
29Product quality issueFAERS: 40US FAERS
30HypotensionFAERS: 37
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
31ConstipationFAERS: 32
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
32SyncopeFAERS: 32
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
33Oropharyngeal painFAERS: 31
Canada Vigilance: 5
Canada Vigilance
US FAERS
34Burning sensationFAERS: 29US FAERS
35PalpitationsFAERS: 29
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
36Drug effect incompleteFAERS: 28US FAERS
37Chest discomfortFAERS: 26US FAERS
38Myocardial InfarctionFAERS: 26SIDER
US FAERS
39Cerebrovascular accidentFAERS: 25US FAERS
40Drug ineffective for unapproved indicationFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
41EructationFAERS: 25
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
42PancreatitisFAERS: 25OFFSIDES
SIDER
US FAERS
43Anaphylactic shockFAERS: 24SIDER
US FAERS
44AngioedemaFAERS: 23
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
45Gastrointestinal bacterial overgrowthFAERS: 23US FAERS
46PneumoniaFAERS: 23SIDER
US FAERS
47TremorFAERS: 23
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
48No adverse eventFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
49DysphoniaFAERS: 21US FAERS
50Diabetes MellitusFAERS: 20SIDER
US FAERS
51DysgeusiaFAERS: 20
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
52Product use in unapproved indicationFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
53Product use issueFAERS: 19US FAERS
54Throat irritationFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
55ThrombocytopeniaFAERS: 19SIDER
US FAERS
56GastritisFAERS: 18
Canada Vigilance: 1
16080005CTD
SIDER
Canada Vigilance
US FAERS
57ChillsFAERS: 17SIDER
US FAERS
58VertigoFAERS: 17
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
59SwellingFAERS: 16US FAERS
60NeutropeniaFAERS: 15US FAERS
61Reaction to drug excipientsFAERS: 15US FAERS
62SomnolenceFAERS: 15SIDER
US FAERS
63ArthritisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
64Bone painFAERS: 13
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
65Intentional product misuseFAERS: 13US FAERS
66TinnitusFAERS: 13
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
67Intentional product use issueFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
68Blood magnesium decreasedFAERS: 11US FAERS
69EpistaxisFAERS: 11SIDER
US FAERS
70Intestinal ObstructionFAERS: 11OFFSIDES
US FAERS
71Medication residueFAERS: 11US FAERS
72TachycardiaFAERS: 11
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
73HypophagiaFAERS: 10
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
74InfluenzaFAERS: 10SIDER
US FAERS
75Joint injuryFAERS: 10US FAERS
76Memory impairmentFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
77Mood swingsFAERS: 10SIDER
US FAERS
78Musculoskeletal PainFAERS: 10US FAERS
79NephrolithiasisFAERS: 10OFFSIDES
SIDER
US FAERS
80PresyncopeFAERS: 10US FAERS
81RestlessnessFAERS: 10US FAERS
82Unevaluable eventFAERS: 10US FAERS
83jaundiceFAERS: 10SIDER
US FAERS
84AlopeciaFAERS: 9SIDER
US FAERS
85AmnesiaFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
86Angina PectorisFAERS: 9SIDER
US FAERS
87ArthropathyFAERS: 9SIDER
US FAERS
88Aspartate Aminotransferase IncreasedFAERS: 9SIDER
US FAERS
89ChokingFAERS: 9
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
90Feeling jitteryFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
91HypoparathyroidismFAERS: 9US FAERS
92Impaired work abilityFAERS: 9US FAERS
93LaryngospasmFAERS: 9US FAERS
94NasopharyngitisFAERS: 9SIDER
US FAERS
95PallorFAERS: 9OFFSIDES
US FAERS
96ThrombosisFAERS: 9SIDER
US FAERS
97Wrong technique in drug usage processFAERS: 9US FAERS
98AsthmaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
99Auricular swellingFAERS: 8US FAERS
100Blood cholesterol increasedFAERS: 8US FAERS
101Blood glucose increasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
102DeliriumFAERS: 8US FAERS
103DiscomfortFAERS: 8SIDER
US FAERS
104False positive investigation resultFAERS: 8US FAERS
105FlushingFAERS: 8
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
106Injection site extravasationFAERS: 8US FAERS
107Lip swellingFAERS: 8US FAERS
108MalnutritionFAERS: 8SIDER
US FAERS
109Neck PainFAERS: 8SIDER
US FAERS
110Nonspecific reactionFAERS: 8OFFSIDES
US FAERS
111Therapeutic response unexpected with drug substitutionFAERS: 8US FAERS
112Visual ImpairmentFAERS: 8SIDER
US FAERS
113Accidental exposureFAERS: 7US FAERS
114Adverse eventFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
115Clostridium difficile colitisFAERS: 7OFFSIDES
US FAERS
116Device occlusionFAERS: 7US FAERS
117ExtravasationFAERS: 7US FAERS
118Foreign body in respiratory tractFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
119Intentional drug misuseFAERS: 7US FAERS
120Irritable Bowel SyndromeFAERS: 7US FAERS
121Musculoskeletal stiffnessFAERS: 7
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
122OsteopeniaFAERS: 7US FAERS
123Stevens-Johnson SyndromeFAERS: 725811541CTD
OFFSIDES
SIDER
US FAERS
124StressFAERS: 7US FAERS
125Suicide attemptFAERS: 7US FAERS
126Supraventricular tachycardiaFAERS: 7OFFSIDES
US FAERS
127treatment failureFAERS: 7US FAERS
128Activities of daily living impairedFAERS: 6OFFSIDES
US FAERS
129Alanine Aminotransferase IncreasedFAERS: 6OFFSIDES
SIDER
US FAERS
130Autoimmune hepatitisFAERS: 6US FAERS
131Back disorderFAERS: 6US FAERS
132Blood urine presentFAERS: 6US FAERS
133CholestasisFAERS: 6US FAERS
134Clostridium difficile infectionFAERS: 6US FAERS
135Cold sweatFAERS: 6OFFSIDES
US FAERS
136Drug withdrawal syndromeFAERS: 6US FAERS
137Incorrect dose administeredFAERS: 6US FAERS
138Incorrect route of drug administrationFAERS: 6US FAERS
139InfectionFAERS: 6OFFSIDES
SIDER
US FAERS
140LethargyFAERS: 6US FAERS
141Medication ErrorFAERS: 6US FAERS
142Oral painFAERS: 6US FAERS
143OsteoporosisFAERS: 6US FAERS
144PancytopeniaFAERS: 6SIDER
US FAERS
145Pharmaceutical product complaintFAERS: 6US FAERS
146Rash erythematousFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
147Skin ErosionFAERS: 6US FAERS
148Skin reactionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
149Throat cancerFAERS: 6US FAERS
150Wrong technique in product usage processFAERS: 6US FAERS
151Bone density decreasedFAERS: 5US FAERS
152BronchospasmFAERS: 5US FAERS
153Cardiac ArrestFAERS: 5US FAERS
154ChromaturiaFAERS: 5OFFSIDES
US FAERS
155Drug dose omissionFAERS: 5OFFSIDES
US FAERS
156Eye painFAERS: 5US FAERS
157HerniaFAERS: 5OFFSIDES
SIDER
US FAERS
158Incorrect drug administration durationFAERS: 5US FAERS
159Infusion Site ExtravasationFAERS: 5US FAERS
160Joint swellingFAERS: 5US FAERS
161LeukopeniaFAERS: 5SIDER
US FAERS
162Musculoskeletal discomfortFAERS: 5SIDER
US FAERS
163Product solubility abnormalFAERS: 5US FAERS
164Respiratory distressFAERS: 5US FAERS
165SinusitisFAERS: 5SIDER
US FAERS
166Therapeutic response unexpectedFAERS: 5US FAERS
167Therapy non-responderFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
168UlcerFAERS: 512353402CTD
OFFSIDES
US FAERS
169Urinary tract infectionFAERS: 5SIDER
US FAERS
170nervous system disorderFAERS: 5SIDER
US FAERS
171Abdominal rigidityFAERS: 4US FAERS
172AgeusiaFAERS: 4SIDER
US FAERS
173BlindnessFAERS: 4US FAERS
174Blood iron decreasedFAERS: 4US FAERS
175CellulitisFAERS: 4OFFSIDES
US FAERS
176Circumstance or information capable of leading to medication errorFAERS: 4US FAERS
177ColitisFAERS: 4SIDER
US FAERS
178DeafnessFAERS: 4OFFSIDES
SIDER
US FAERS
179DehydrationFAERS: 4
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
180Disease recurrenceFAERS: 4OFFSIDES
US FAERS
181DisorientationFAERS: 4SIDER
US FAERS
182Drug administration errorFAERS: 4US FAERS
183Drug prescribing errorFAERS: 4US FAERS
184Dry skinFAERS: 4OFFSIDES
SIDER
US FAERS
185EosinophiliaFAERS: 4SIDER
US FAERS
186Epigastric discomfortFAERS: 4US FAERS
187Feeding tube complicationFAERS: 4US FAERS
188FibromyalgiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
189FrustrationFAERS: 4US FAERS
190Gastric pH decreasedFAERS: 4US FAERS
191Gastric ulcerFAERS: 4OFFSIDES
US FAERS
192General physical health deteriorationFAERS: 4OFFSIDES
US FAERS
193Inappropriate schedule of drug administrationFAERS: 4US FAERS
194Kounis SyndromeFAERS: 4US FAERS
195LymphadenopathyFAERS: 4US FAERS
196Mental impairmentFAERS: 4US FAERS
197Multiple SclerosisFAERS: 4US FAERS
198Night sweatsFAERS: 4US FAERS
199Nuchal RigidityFAERS: 4SIDER
US FAERS
200NystagmusFAERS: 4US FAERS
201OverdoseFAERS: 4US FAERS
202Peripheral swellingFAERS: 4US FAERS
203Post procedural complicationFAERS: 4US FAERS
204Product physical issueFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
205Product size issueFAERS: 4US FAERS
206Productive CoughFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
207RegurgitationFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
208RetchingFAERS: 4SIDER
US FAERS
209RhabdomyolysisFAERS: 4OFFSIDES
SIDER
US FAERS
210Suspected counterfeit productFAERS: 4US FAERS
211Toxic Epidermal NecrolysisFAERS: 4SIDER
US FAERS
212WheezingFAERS: 4US FAERS
213AcneFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
214AnosmiaFAERS: 3US FAERS
215AtaxiaFAERS: 3OFFSIDES
US FAERS
216Blood creatine phosphokinase increasedFAERS: 3SIDER
US FAERS
217BronchitisFAERS: 3OFFSIDES
SIDER
US FAERS
218Carbohydrate antigen 19-9 increasedFAERS: 3US FAERS
219Cholecystitis infectiveFAERS: 3US FAERS
220CholecystitisFAERS: 3OFFSIDES
SIDER
US FAERS
221Clostridium test positiveFAERS: 3US FAERS
222ConjunctivitisFAERS: 3SIDER
US FAERS
223Corneal graft rejectionFAERS: 3US FAERS
224DiplopiaFAERS: 3SIDER
US FAERS
225DisabilityFAERS: 3US FAERS
226Drug DependenceFAERS: 3US FAERS
227EczemaFAERS: 3OFFSIDES
SIDER
US FAERS
228Erectile dysfunctionFAERS: 3SIDER
US FAERS
229Eye irritationFAERS: 3US FAERS
230Facial PainFAERS: 3US FAERS
231Fibroadenoma of breastFAERS: 3US FAERS
232Food AllergyFAERS: 3US FAERS
233FractureFAERS: 3SIDER
US FAERS
234Gastrointestinal PainFAERS: 3
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
235GoutFAERS: 3OFFSIDES
SIDER
US FAERS
236Granulomatous dermatitisFAERS: 3US FAERS
237Hepatitis CFAERS: 3US FAERS
238HepatotoxicityFAERS: 3US FAERS
239HyperaldosteronismFAERS: 3US FAERS
240HyperchlorhydriaFAERS: 3US FAERS
241HypokinesiaFAERS: 3SIDER
US FAERS
242HypothyroidismFAERS: 3US FAERS
243InflammationFAERS: 3SIDER
US FAERS
244Injection site erythemaFAERS: 3OFFSIDES
US FAERS
245Interventional procedureFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
246LaryngitisFAERS: 3SIDER
US FAERS
247LeukocytosisFAERS: 3SIDER
US FAERS
248Limb discomfortFAERS: 3US FAERS
249Limb injuryFAERS: 3US FAERS
250Mental status changesFAERS: 3OFFSIDES
US FAERS
251Mineral supplementationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
252Muscle tightnessFAERS: 3OFFSIDES
US FAERS
253MyositisFAERS: 3US FAERS
254Nasal discomfortFAERS: 3US FAERS
255NephritisFAERS: 3US FAERS
256NervousnessFAERS: 3SIDER
US FAERS
257Occult blood positiveFAERS: 3US FAERS
258Oral mucosal erythemaFAERS: 3US FAERS
259Pulmonary congestionFAERS: 3OFFSIDES
US FAERS
260Renal cystFAERS: 3US FAERS
261Respiratory tract congestionFAERS: 3OFFSIDES
US FAERS
262Retinal vascular thrombosisFAERS: 3US FAERS
263SepsisFAERS: 3SIDER
US FAERS
264Skin lesionFAERS: 3OFFSIDES
US FAERS
265Subacute hepatic failureFAERS: 3US FAERS
266Vitamin D DeficiencyFAERS: 3US FAERS
267White blood cell count decreasedFAERS: 3US FAERS
268Accidental overdoseFAERS: 2US FAERS
269Acute respiratory failureFAERS: 2US FAERS
270AgitationFAERS: 2SIDER
US FAERS
271Ankle FractureFAERS: 2US FAERS
272AnorexiaFAERS: 2OFFSIDES
SIDER
US FAERS
273AphasiaFAERS: 2US FAERS
274AsphyxiaFAERS: 2US FAERS
275AsthenopiaFAERS: 2US FAERS
276BlepharitisFAERS: 2US FAERS
277Blood creatinine decreasedFAERS: 2US FAERS
278Blood potassium decreasedFAERS: 2OFFSIDES
SIDER
US FAERS
279Breakthrough PainFAERS: 2OFFSIDES
US FAERS
280CataractFAERS: 2SIDER
US FAERS
281Cerebral ThrombosisFAERS: 2US FAERS
282CholelithiasisFAERS: 2SIDER
US FAERS
283Completed SuicideFAERS: 2US FAERS
284Complication associated with deviceFAERS: 2US FAERS
285CystitisFAERS: 2SIDER
US FAERS
286Dental cariesFAERS: 2US FAERS
287Depressed moodFAERS: 2US FAERS
288Dermatitis HerpetiformisFAERS: 2US FAERS
289Dermatitis acneiformFAERS: 2US FAERS
290DermatomyositisFAERS: 2US FAERS
291Drug exposure during pregnancyFAERS: 2US FAERS
292DysarthriaFAERS: 2SIDER
US FAERS
293DysuriaFAERS: 2OFFSIDES
SIDER
US FAERS
294Emotional distressFAERS: 2OFFSIDES
US FAERS
295Erythema MultiformeFAERS: 2SIDER
US FAERS
296Expired product administeredFAERS: 2US FAERS
297Feeling ColdFAERS: 2OFFSIDES
US FAERS
298Feeling of body temperature changeFAERS: 2US FAERS
299Gamma-Glutamyltransferase IncreasedFAERS: 2SIDER
US FAERS
300HepatitisFAERS: 212649798CTD
OFFSIDES
SIDER
US FAERS
301HyperplasiaFAERS: 2US FAERS
302Hypertensive crisisFAERS: 2US FAERS
303Impaired gastric emptyingFAERS: 2US FAERS
304Increased upper airway secretionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
305Injection site vesiclesFAERS: 2US FAERS
306Intervertebral disc disorderFAERS: 2US FAERS
307Laboratory test interferenceFAERS: 2US FAERS
308Lactose IntoleranceFAERS: 2US FAERS
309LymphocytosisFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
310MalabsorptionFAERS: 2US FAERS
311MetrorrhagiaFAERS: 2US FAERS
312Middle insomniaFAERS: 2US FAERS
313MyopathyFAERS: 2US FAERS
314Pancreatic Enzymes DecreasedFAERS: 2US FAERS
315Periorbital swellingFAERS: 2US FAERS
316PeriostitisFAERS: 2US FAERS
317PhotophobiaFAERS: 2SIDER
US FAERS
318Poor quality product administeredFAERS: 2US FAERS
319ProctitisFAERS: 2US FAERS
320Product difficult to swallowFAERS: 2US FAERS
321Product formulation issueFAERS: 2US FAERS
322Product label issueFAERS: 2US FAERS
323Product taste abnormalFAERS: 2US FAERS
324Protein urine presentFAERS: 2US FAERS
325PsoriasisFAERS: 2US FAERS
326Rectal fissureFAERS: 2US FAERS
327Rectal polypFAERS: 2US FAERS
328Renal painFAERS: 2SIDER
US FAERS
329Respiratory FailureFAERS: 2US FAERS
330Retinal DetachmentFAERS: 2US FAERS
331Saliva alteredFAERS: 2US FAERS
332SciaticaFAERS: 2US FAERS
333ShockFAERS: 2SIDER
US FAERS
334Skin UlcerFAERS: 2SIDER
US FAERS
335Stem cell transplantFAERS: 2US FAERS
336Therapy cessationFAERS: 2US FAERS
337Tongue blisteringFAERS: 2OFFSIDES
US FAERS
338Tongue discomfortFAERS: 2US FAERS
339ToothacheFAERS: 2SIDER
US FAERS
340Unresponsive to stimuliFAERS: 2US FAERS
341Vascular occlusionFAERS: 2US FAERS
342Ventricular arrhythmiaFAERS: 2US FAERS
343Visual disturbanceFAERS: 2SIDER
US FAERS
344Vitreous floatersFAERS: 2US FAERS
345Wrong drug administeredFAERS: 2US FAERS
346AbasiaFAERS: 1OFFSIDES
US FAERS
347Accidental exposure to productFAERS: 1US FAERS
348AchlorhydriaFAERS: 1US FAERS
349AgranulocytosisFAERS: 1SIDER
US FAERS
350Alcohol test false positiveFAERS: 1US FAERS
351Allergic reaction to excipientFAERS: 1US FAERS
352Altered state of consciousnessFAERS: 1US FAERS
353Anal FissureFAERS: 1US FAERS
354Anaphylactoid ReactionFAERS: 1US FAERS
355Anorectal discomfortFAERS: 1US FAERS
356AphagiaFAERS: 1US FAERS
357Aphthous StomatitisFAERS: 1SIDER
US FAERS
358Application site erythemaFAERS: 1US FAERS
359Application site painFAERS: 1US FAERS
360AscitesFAERS: 1OFFSIDES
US FAERS
361Atrial FibrillationFAERS: 1SIDER
US FAERS
362Basal cell carcinomaFAERS: 1US FAERS
363BedriddenFAERS: 1US FAERS
364Blood 25-hydroxycholecalciferol decreasedFAERS: 1US FAERS
365Blood alcohol increasedFAERS: 1US FAERS
366Blood blisterFAERS: 1US FAERS
367Blood cholesterol abnormalFAERS: 1US FAERS
368Blood creatinine increasedFAERS: 1OFFSIDES
SIDER
US FAERS
369Blood glucose abnormalFAERS: 1US FAERS
370Blood ketone body decreasedFAERS: 1US FAERS
371Blood phosphorus decreasedFAERS: 1US FAERS
372Blood potassium abnormalFAERS: 1US FAERS
373Blood pressure fluctuationFAERS: 1US FAERS
374Blood sodium abnormalFAERS: 1US FAERS
375Bone density abnormalFAERS: 1US FAERS
376Bowel movement irregularityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
377BradycardiaFAERS: 1OFFSIDES
US FAERS
378Breast tendernessFAERS: 1US FAERS
379CandidiasisFAERS: 1US FAERS
380CarcinomaFAERS: 1US FAERS
381Cardiac TamponadeFAERS: 1US FAERS
382Cardioactive drug level increasedFAERS: 1US FAERS
383Carpal Tunnel SyndromeFAERS: 1US FAERS
384Catheter site infectionFAERS: 1US FAERS
385Catheter site painFAERS: 1US FAERS
386Catheter site phlebitisFAERS: 1US FAERS
387Catheter site related reactionFAERS: 1US FAERS
388Cervix carcinomaFAERS: 1US FAERS
389CheilitisFAERS: 1US FAERS
390Chemical burn of gastrointestinal tractFAERS: 1US FAERS
391Colon adenomaFAERS: 1US FAERS
392Complications of maternal exposure to therapeutic drugsFAERS: 1US FAERS
393Contraindicated drug prescribedFAERS: 1US FAERS
394Contraindicated product prescribedFAERS: 1US FAERS
395CycloplegiaFAERS: 1US FAERS
396DementiaFAERS: 1US FAERS
397DermatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
398Device breakageFAERS: 1US FAERS
399Device connection issueFAERS: 1US FAERS
400Device related infectionFAERS: 1OFFSIDES
US FAERS
401Diabetic ulcerFAERS: 1US FAERS
402Disturbance in sexual arousalFAERS: 1SIDER
US FAERS
403DiverticulumFAERS: 1US FAERS
404Drug abuserFAERS: 1US FAERS
405Drug dispensing errorFAERS: 1US FAERS
406Drug effect delayedFAERS: 1US FAERS
407Drug effective for unapproved indicationFAERS: 1US FAERS
408Drug resistanceFAERS: 1US FAERS
409DyscheziaFAERS: 1US FAERS
410Electrocardiogram ST segment abnormalFAERS: 1US FAERS
411Electrocardiogram repolarisation abnormalityFAERS: 1US FAERS
412Electroencephalogram abnormalFAERS: 1US FAERS
413Electrolyte imbalanceFAERS: 1US FAERS
414Emotional disorderFAERS: 1US FAERS
415EndometriosisFAERS: 1US FAERS
416Enterobacter pneumoniaFAERS: 1OFFSIDES
US FAERS
417EpiglottitisFAERS: 1US FAERS
418Erythema NodosumFAERS: 1US FAERS
419ErythropeniaFAERS: 1US FAERS
420Euphoric moodFAERS: 1US FAERS
421Extra dose administeredFAERS: 1US FAERS
422Extraocular Muscle ParesisFAERS: 1US FAERS
423Flank PainFAERS: 1US FAERS
424FormicationFAERS: 1US FAERS
425Full blood count decreasedFAERS: 1OFFSIDES
US FAERS
426Full blood count increasedFAERS: 1US FAERS
427Gait inabilityFAERS: 1US FAERS
428Gallbladder painFAERS: 1US FAERS
429Gastric hypomotilityFAERS: 1US FAERS
430GastroenteritisFAERS: 1OFFSIDES
SIDER
US FAERS
431Gastrointestinal carcinomaFAERS: 1SIDER
US FAERS
432Gastrointestinal sounds abnormalFAERS: 1US FAERS
433Gastrointestinal stoma complicationFAERS: 1US FAERS
434Gastrointestinal wall abnormalFAERS: 1US FAERS
435Genital HerpesFAERS: 1US FAERS
436GlomerulonephritisFAERS: 1US FAERS
437Head discomfortFAERS: 1US FAERS
438Hepatorenal SyndromeFAERS: 1US FAERS
439HordeolumFAERS: 1US FAERS
440HungerFAERS: 1US FAERS
441HyperkeratosisFAERS: 1OFFSIDES
US FAERS
442IleitisFAERS: 1OFFSIDES
US FAERS
443Impaired driving abilityFAERS: 1US FAERS
444IncontinenceFAERS: 1OFFSIDES
US FAERS
445Incorrect storage of drugFAERS: 1US FAERS
446InfarctionFAERS: 1US FAERS
447Infrequent bowel movementsFAERS: 1US FAERS
448Infusion site abscessFAERS: 1US FAERS
449Infusion site cellulitisFAERS: 1US FAERS
450Infusion site erythemaFAERS: 1US FAERS
451Infusion site painFAERS: 1US FAERS
452Infusion site swellingFAERS: 1US FAERS
453Injection Site ReactionFAERS: 1SIDER
US FAERS
454Injection site inflammationFAERS: 1US FAERS
455Injection site necrosisFAERS: 1US FAERS
456Injection site painFAERS: 1US FAERS
457Injection site phlebitisFAERS: 1US FAERS
458Injection site warmthFAERS: 1US FAERS
459Intention tremorFAERS: 1OFFSIDES
US FAERS
460Intercepted drug dispensing errorFAERS: 1US FAERS
461Intestinal PerforationFAERS: 1US FAERS
462Intracranial AneurysmFAERS: 1US FAERS
463Iron deficiencyFAERS: 1US FAERS
464Joint stiffnessFAERS: 1OFFSIDES
US FAERS
465Lactation DisorderFAERS: 1US FAERS
466Latex allergyFAERS: 1US FAERS
467Lichen PlanusFAERS: 1US FAERS
468Ligament ruptureFAERS: 1US FAERS
469Long QT SyndromeFAERS: 1US FAERS
470Low density lipoprotein increasedFAERS: 1US FAERS
471Lower respiratory tract congestionFAERS: 1US FAERS
472Lower respiratory tract infectionFAERS: 1US FAERS
473Lupus-like syndromeFAERS: 1US FAERS
474LymphomaFAERS: 1OFFSIDES
US FAERS
475Macular degenerationFAERS: 1US FAERS
476MaculeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
477Malignant neoplasm progressionFAERS: 1OFFSIDES
US FAERS
478MarasmusFAERS: 1US FAERS
479Maternal exposure during pregnancyFAERS: 1US FAERS
480Meconium abnormalFAERS: 1US FAERS
481Medication residue presentFAERS: 1US FAERS
482Metabolic acidosisFAERS: 1OFFSIDES
US FAERS
483MetaplasiaFAERS: 1US FAERS
484MetastasisFAERS: 1US FAERS
485Migraine with AuraFAERS: 1US FAERS
486MiliariaFAERS: 1US FAERS
487Motion SicknessFAERS: 1US FAERS
488Mouth swellingFAERS: 1US FAERS
489Muscle strainFAERS: 1US FAERS
490Mycosis FungoidesFAERS: 1US FAERS
491MydriasisFAERS: 1US FAERS
492Myoglobin blood increasedFAERS: 1US FAERS
493Nasogastric output abnormalFAERS: 1US FAERS
494NephrocalcinosisFAERS: 1US FAERS
495NeuralgiaFAERS: 1SIDER
US FAERS
496NeuritisFAERS: 1SIDER
US FAERS
497Nipple painFAERS: 1US FAERS
498No reaction on previous exposure to drugFAERS: 1US FAERS
499OligohydramniosFAERS: 1US FAERS
500Open woundFAERS: 1US FAERS
501Opiates positiveFAERS: 1US FAERS
502Optic NeuritisFAERS: 1US FAERS
503Optic NeuropathyFAERS: 1US FAERS
504Oral candidiasisFAERS: 1SIDER
US FAERS
505Oral mucosal exfoliationFAERS: 1US FAERS
506Oropharyngeal swellingFAERS: 1US FAERS
507Orthostatic intoleranceFAERS: 1US FAERS
508OsteolysisFAERS: 1US FAERS
509Pain of skinFAERS: 1OFFSIDES
US FAERS
510Pancreatic CystFAERS: 1US FAERS
511Pancreatic carcinomaFAERS: 1US FAERS
512PancreaticoduodenectomyFAERS: 1US FAERS
513Peptic UlcerFAERS: 1
Canada Vigilance: 1
7762175
19837071
CTD
Canada Vigilance
US FAERS
514PeriarthritisFAERS: 1US FAERS
515Pharyngeal polypFAERS: 1US FAERS
516PharyngitisFAERS: 1SIDER
US FAERS
517Pharyngolaryngeal PainFAERS: 1US FAERS
518Platelet count abnormalFAERS: 1US FAERS
519PoisoningFAERS: 1US FAERS
520PolydipsiaFAERS: 1US FAERS
521Polymyalgia RheumaticaFAERS: 1US FAERS
522Poor peripheral circulationFAERS: 1US FAERS
523Poor quality drug administeredFAERS: 1US FAERS
524Poor quality sleepFAERS: 1US FAERS
525Predisposition to diseaseFAERS: 1US FAERS
526Product administration errorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
527Product complaintFAERS: 1US FAERS
528Product contamination physicalFAERS: 1US FAERS
529Product lot number issueFAERS: 1US FAERS
530Product packaging quantity issueFAERS: 1US FAERS
531Product preparation errorFAERS: 1US FAERS
532Product shape issueFAERS: 1US FAERS
533Product storage errorFAERS: 1US FAERS
534Product tamperingFAERS: 1US FAERS
535Product use complaintFAERS: 1US FAERS
536Protein S DeficiencyFAERS: 1US FAERS
537Protein total increasedFAERS: 1US FAERS
538Pruritus allergicFAERS: 1US FAERS
539Reaction to excipientFAERS: 1US FAERS
540Rebound effectFAERS: 1US FAERS
541Respiratory tract irritationFAERS: 1US FAERS
542Restless Legs SyndromeFAERS: 1US FAERS
543Rheumatic disorderFAERS: 1US FAERS
544ScabFAERS: 1US FAERS
545Secretion dischargeFAERS: 1US FAERS
546Septic ShockFAERS: 1US FAERS
547Sjogren's SyndromeFAERS: 1US FAERS
548Skeletal injuryFAERS: 1US FAERS
549Skin PapillomaFAERS: 1US FAERS
550Skin irritationFAERS: 1US FAERS
551SluggishnessFAERS: 1US FAERS
552Smoke sensitivityFAERS: 1US FAERS
553SmokerFAERS: 1US FAERS
554Spinal column injuryFAERS: 1US FAERS
555SplenectomyFAERS: 1OFFSIDES
US FAERS
556SpondylitisFAERS: 1US FAERS
557StomatitisFAERS: 1SIDER
US FAERS
558Stress ulcerFAERS: 1US FAERS
559TachyphylaxisFAERS: 1US FAERS
560Therapeutic product cross-reactivityFAERS: 1US FAERS
561Therapeutic product effect delayedFAERS: 1US FAERS
562Therapeutic product effect incompleteFAERS: 1US FAERS
563Therapy regimen changedFAERS: 1US FAERS
564ThrombophlebitisFAERS: 1SIDER
US FAERS
565Thrombosis in deviceFAERS: 1US FAERS
566Tongue bitingFAERS: 1US FAERS
567Toxicity to various agentsFAERS: 1US FAERS
568Transaminases increasedFAERS: 1OFFSIDES
SIDER
US FAERS
569Tri-iodothyronine uptake increasedFAERS: 1US FAERS
570TrismusFAERS: 1US FAERS
571Umbilical herniaFAERS: 1US FAERS
572Urinary IncontinenceFAERS: 1US FAERS
573Urinary RetentionFAERS: 1US FAERS
574Urinary Tract PainFAERS: 1US FAERS
575Urine alcohol test positiveFAERS: 1US FAERS
576Urine output increasedFAERS: 1US FAERS
577Uterine PolypFAERS: 1OFFSIDES
US FAERS
578UveitisFAERS: 1US FAERS
579VasospasmFAERS: 1US FAERS
580Vitreous DetachmentFAERS: 1US FAERS
581Vitreous opacitiesFAERS: 1US FAERS
582Vocal Cord ParalysisFAERS: 1US FAERS
583furuncleFAERS: 1US FAERS
584Abdominal AbscessOFFSIDES
585Abdominal InfectionOFFSIDES
586Abdominal bloatingSIDER
587Abdominal sepsisOFFSIDES
588Abdominal tendernessSIDER
589Abdominal wall infectionOFFSIDES
590Abnormal visionSIDER
591AbscessOFFSIDES
SIDER
592Acid refluxOFFSIDES
593AcidosisOFFSIDES
594Acquired diaphragmatic eventrationOFFSIDES
595Acute Coronary SyndromeSIDER
596Acute graft versus host disease in liverOFFSIDES
597AdenocarcinomaOFFSIDES
598AdenomaOFFSIDES
599Adjustment disorder with depressed moodOFFSIDES
600AgraphiaOFFSIDES
601Alanine aminotransferase abnormalOFFSIDES
602AlbuminuriaSIDER
603AlveolitisOFFSIDES
604AmblyopiaSIDER
605Anastomotic ulcerOFFSIDES
606AnhedoniaOFFSIDES
607Anterior Ischemic Optic NeuropathySIDER
608Antidepressant drug level above therapeuticOFFSIDES
609ApathyOFFSIDES
610Application site pruritusOFFSIDES
611Aspartate aminotransferase abnormalOFFSIDES
612Aspiration PneumoniaOFFSIDES
613AtelectasisOFFSIDES
614Atrial FlutterOFFSIDES
615Atrial tachycardiaOFFSIDES
616Autonomic neuropathySIDER
617Avascular necrosisOFFSIDES
618BalanitisSIDER
619Band neutrophil percentage increasedOFFSIDES
620Barrett Esophagus12077038CTD
621Biliary ColicSIDER
622Biopsy liver abnormalOFFSIDES
623Bipolar DisorderOFFSIDES
624Bipolar I disorderOFFSIDES
625Bladder painSIDER
626Blood 1,25-dihydroxycholecalciferol decreasedOFFSIDES
627Blood GlucoseOFFSIDES
628Blood alkaline phosphatase increasedOFFSIDES
SIDER
629Blood and lymphatic system disordersSIDER
630Blood cholesterolOFFSIDES
631Blood cholinesterase decreasedOFFSIDES
632Blood glucose decreasedOFFSIDES
633Blood iron increasedOFFSIDES
634Blood potassium increasedSIDER
635Blood sodiumOFFSIDES
636Blood thyroid stimulating hormoneOFFSIDES
637Blood triglycerides increasedOFFSIDES
SIDER
638Blood urea increasedOFFSIDES
639Blurred visionOFFSIDES
640Borderline Personality DisorderOFFSIDES
641Brain DeathOFFSIDES
642Brain HypoxiaOFFSIDES
643Buccal inflammationSIDER
644BursitisSIDER
645CalciphylaxisOFFSIDES
646CandiduriaOFFSIDES
647Cardiac FlutterSIDER
648Carotid artery aneurysmOFFSIDES
649Cataract specifiedSIDER
650Catheter placementOFFSIDES
651Catheter related infectionOFFSIDES
652Cauda Equina SyndromeOFFSIDES
653Cerebrovascular accident prophylaxisOFFSIDES
654Chemical and Drug Induced Liver Injury12649798CTD
655Choking sensationOFFSIDES
656Chronic Obstructive Airway DiseaseOFFSIDES
657ColectomyOFFSIDES
658Colonic StenosisOFFSIDES
659ConfabulationOFFSIDES
660Cramps of lower extremitiesSIDER
661Creatine Phosphokinase IncreasedSIDER
662Creatinine increasedSIDER
663Creatinine renal clearance decreasedSIDER
664DemyelinationOFFSIDES
665Depression suicidalOFFSIDES
666DiabetesOFFSIDES
667Diabetes mellitus inadequate controlOFFSIDES
668Diaphragmatic HerniaOFFSIDES
669Diarrhea11012560
11173893
CTD
OFFSIDES
670Disease ProgressionOFFSIDES
671Disorders of Excessive Somnolence18656731CTD
672DiverticulitisOFFSIDES
673DrowsinessOFFSIDES
674Drug specific antibody absentOFFSIDES
675DuodenitisSIDER
676Dyspeptic signs and symptomsSIDER
677EcchymosisSIDER
678Edema11341670CTD
679Electrocardiogram ST-T changeOFFSIDES
680Electrocardiogram abnormalSIDER
681EnteritisSIDER
682EpididymitisSIDER
683Erosive gastritisOFFSIDES
684Escherichia infectionOFFSIDES
685Esophageal PerforationOFFSIDES
686Esophagitis11519776CTD
687ExcoriationOFFSIDES
688External OphthalmoplegiaSIDER
689Extremity contractureOFFSIDES
690Facial wastingOFFSIDES
691Fatty LiverOFFSIDES
692Febrile NeutropeniaOFFSIDES
693Fluid overloadOFFSIDES
694GamblingOFFSIDES
695Gastrointestinal Hemorrhage18162722CTD
696Gastrointestinal candidiasisSIDER
697Gastrointestinal motility disorderOFFSIDES
698GingivitisSIDER
699GlaucomaSIDER
700GlossitisSIDER
701Glucose increasedSIDER
702GlycosuriaSIDER
703GranulocytosisOFFSIDES
704Headache dullSIDER
705Heat StrokeSIDER
706Helicobacter Infections

View details

CTD
707Hepatic necrosisOFFSIDES
708Hepatosplenic T-cell lymphomaOFFSIDES
709HepatosplenomegalyOFFSIDES
710HiccoughOFFSIDES
711HistoplasmosisOFFSIDES
712HyperkinesiaSIDER
713HyperpigmentationOFFSIDES
714HyperreflexiaOFFSIDES
715Hypertensive emergencyOFFSIDES
716HyporeflexiaSIDER
717HypoxiaOFFSIDES
718IncoherentOFFSIDES
719InfestationSIDER
720Infusion site mobility decreasedOFFSIDES
721Inguinal massOFFSIDES
722Injection site irritationOFFSIDES
723Injection site maculeOFFSIDES
724Injection site pruritusOFFSIDES
725Injection site thrombosisSIDER
726Injection site urticariaOFFSIDES
727Intestinal FistulaOFFSIDES
728Intestinal resectionOFFSIDES
729Joint InstabilityOFFSIDES
730Joint Range of Motion DecreasedOFFSIDES
731Kidney FailureOFFSIDES
732Left Ventricular HypertrophyOFFSIDES
733LegionellaOFFSIDES
734Life expectancy shortenedOFFSIDES
735Lip erosionOFFSIDES
736Liver neoplasms25058030CTD
737Lyme DiseaseOFFSIDES
738Mechanical ventilationOFFSIDES
739Medical device complicationOFFSIDES
740MegacolonOFFSIDES
741Multi-organ disorderOFFSIDES
742Muscle WeaknessOFFSIDES
743MyelofibrosisCanada Vigilance: 1Canada Vigilance
744Neck stiffnessSIDER
745Nephritis, Interstitial

View details

CTD
746Nephrogenic Fibrosing DermopathyOFFSIDES
747NeuropathySIDER
748NocturiaSIDER
749Non-accidental injurySIDER
750ObstructionOFFSIDES
751Oesophageal reflux aggravatedSIDER
752OphthalmoplegiaSIDER
753Oral infectionOFFSIDES
754OsteochondrosisOFFSIDES
755OsteoradionecrosisOFFSIDES
756Otitis ExternaSIDER
757OtosclerosisOFFSIDES
758PO2 decreasedOFFSIDES
759ParotitisOFFSIDES
760Pericardial effusionOFFSIDES
761PeriodontitisSIDER
762Peritonsillar AbscessOFFSIDES
763Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
764Physical disabilityOFFSIDES
765PleurisyOFFSIDES
766PneumobiliaOFFSIDES
767Post procedural bile leakOFFSIDES
768Post procedural infectionOFFSIDES
769Posterior capsule opacificationOFFSIDES
770Postoperative Hemorrhage18162722CTD
771Potassium increasedSIDER
772Potassium lowSIDER
773Premature EjaculationCanada Vigilance: 1Canada Vigilance
774Prepyloric stenosisOFFSIDES
775ProctocolitisSIDER
776Protein total decreasedOFFSIDES
777PyelonephritisSIDER
778Quality of life decreasedOFFSIDES
779Recurrence17230024CTD
780Renal Artery StenosisOFFSIDES
781Reticulocyte count decreasedOFFSIDES
782Retinal Vascular DisorderSIDER
783Retrosternal painSIDER
784RhinitisSIDER
785RhinorrheaOFFSIDES
786Skin IndurationOFFSIDES
787Skin WrinklingOFFSIDES
788Skin hypertrophyOFFSIDES
789Skin tightnessOFFSIDES
790Sleep disorder due to general medical condition, insomnia typeCanada Vigilance: 1Canada Vigilance
791SneezingCanada Vigilance: 1Canada Vigilance
792SoporOFFSIDES
793Staphylococcal abscessOFFSIDES
794Stent occlusionOFFSIDES
795Subcutaneous noduleOFFSIDES
796Surgical vascular shuntOFFSIDES
797SweatingSIDER
798Taste Disorders11173893CTD
SIDER
799TenosynovitisSIDER
800TensionSIDER
801Therapeutic product effect decreasedCanada Vigilance: 5Canada Vigilance
802Therapeutic response changedCanada Vigilance: 33Canada Vigilance
803ThirstSIDER
804Thrombophlebitis injection siteSIDER
805Tinea PedisOFFSIDES
806Tonic clonic movementsOFFSIDES
807TonsillitisSIDER
808Tracheal StenosisOFFSIDES
809TracheitisOFFSIDES
810TracheobronchitisOFFSIDES
811Urethritis noninfectiveSIDER
812UrethritisSIDER
813Uterine spasmOFFSIDES
814Vanishing bile duct syndromeOFFSIDES
815Vasculitis, Leukocytoclastic, Cutaneous16482642CTD
816Vasodilation procedureSIDER
817VasodilationSIDER
818Ventricular FibrillationOFFSIDES
819Vitamin A DeficiencyOFFSIDES
820Wound infection staphylococcalOFFSIDES
821Zollinger-Ellison syndrome11774936CTD
822muscle injuryOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.